LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended on June 30 2024 along with any other business if any.